BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis

FRA:BRYN • US0846707026

422 EUR
-5.25 (-1.23%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, BRYN scores 5 out of 10 in our fundamental rating. BRYN was compared to 59 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make BRYN a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • BRYN had positive earnings in the past year.
  • In the past year BRYN had a positive cash flow from operations.
  • Of the past 5 years BRYN 4 years were profitable.
  • In the past 5 years BRYN always reported a positive cash flow from operatings.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

  • The Return On Assets of BRYN (5.50%) is better than 79.66% of its industry peers.
  • Looking at the Return On Equity, with a value of 9.66%, BRYN is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.53%, BRYN is in line with its industry, outperforming 55.93% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 9.72%.
  • The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROIC 4.53%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • BRYN has a better Profit Margin (18.13%) than 69.49% of its industry peers.
  • BRYN's Profit Margin has declined in the last couple of years.
  • BRYN has a Operating Margin (16.72%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of BRYN has grown nicely.
  • BRYN has a worse Gross Margin (17.71%) than 64.41% of its industry peers.
  • BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
  • Compared to 1 year ago, BRYN has less shares outstanding
  • The number of shares outstanding for BRYN has been reduced compared to 5 years ago.
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

  • BRYN has an Altman-Z score of 1.36. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
  • BRYN has a Altman-Z score (1.36) which is in line with its industry peers.
  • BRYN has a debt to FCF ratio of 6.58. This is a slightly negative value and a sign of low solvency as BRYN would need 6.58 years to pay back of all of its debts.
  • BRYN has a Debt to FCF ratio of 6.58. This is comparable to the rest of the industry: BRYN outperforms 57.63% of its industry peers.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.18, BRYN is in the better half of the industry, outperforming 69.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Altman-Z 1.36
ROIC/WACC1.41
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that BRYN should not have too much problems paying its short term obligations.
  • BRYN's Current ratio of 1.33 is in line compared to the rest of the industry. BRYN outperforms 55.93% of its industry peers.
  • A Quick Ratio of 1.11 indicates that BRYN should not have too much problems paying its short term obligations.
  • BRYN has a Quick ratio of 1.11. This is comparable to the rest of the industry: BRYN outperforms 50.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.11
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.97%, which is quite good.
  • Measured over the past years, BRYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.78% on average per year.
  • The Revenue has been growing slightly by 0.60% in the past year.
  • The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.26% on average over the next years.
  • BRYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.89% yearly.
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 0.01, which indicates a rather cheap valuation of BRYN.
  • Based on the Price/Earnings ratio, BRYN is valued cheaper than 98.31% of the companies in the same industry.
  • BRYN is valuated cheaply when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 0.02, which indicates a rather cheap valuation of BRYN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 98.31% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, BRYN is valued rather cheaply.
Industry RankSector Rank
PE 0.01
Fwd PE 0.02
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaper than 91.53% of the companies in the same industry.
  • BRYN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRYN is cheaper than 98.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.04
EV/EBITDA 0.64
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.31%
EPS Next 3Y1.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (2/13/2026, 7:00:00 PM)

422

-5.25 (-1.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-01
Earnings (Next)02-23
Inst Owners26.93%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap607.68M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target441.06 (4.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)-2.22%
PT rev (3m)-2.03%
EPS NQ rev (1m)-4.39%
EPS NQ rev (3m)3.73%
EPS NY rev (1m)0.12%
EPS NY rev (3m)2.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE 0.02
P/S 0
P/FCF 0.04
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 0.64
EPS(TTM)28584.48
EY6773.57%
EPS(NY)27958.59
Fwd EY6625.26%
FCF(TTM)11302.7
FCFY2678.36%
OCF(TTM)23041.7
OCFY5460.12%
SpS217637.04
BVpS408312.16
TBVpS338340
PEG (NY)N/A
PEG (5Y)0
Graham Number512451
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROCE 5.61%
ROIC 4.53%
ROICexc 4.87%
ROICexgc 5.82%
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
FCFM 5.19%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Debt/EBITDA 1.69
Cap/Depr 151.95%
Cap/Sales 5.39%
Interest Coverage 12.22
Cash Conversion 52.22%
Profit Quality 28.65%
Current Ratio 1.33
Quick Ratio 1.11
Altman-Z 1.36
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.25%
Revenue Next 3Y1.4%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


What is the profitability of BRYN stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.


How financially healthy is BERKSHIRE HATHAWAY INC-CL B?

The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.